SynthesisPharmacoEconomics2024

Rethinking Tuberculosis Morbidity Quantification: A Systematic Review and Critical Appraisal of TB Disability Weights in Cost-Effectiveness Analyses.

Ewan M Tomeny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.